Champions Oncology (CSBR) Revenue (QoQ) (2010 - 2026)
Champions Oncology (CSBR) Revenue (QoQ) (2010 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
| 1 |
Alterity Therapeutics |
814,307.08 Bn |
814,307.05 Bn |
- |
| 2 |
Belite Bio |
55,320.00 Bn |
55,320.00 Bn |
- |
| 3 |
Quantum Biopharma |
17,149.72 Bn |
17,149.72 Bn |
- |
| 4 |
Legend Biotech |
3,590.00 Bn |
3,589.71 Bn |
242.10 Mn |
| 5 |
Akari Therapeutics |
1,650.72 Bn |
1,650.72 Bn |
- |
| 6 |
Evaxion A |
1,522.09 Bn |
1,522.07 Bn |
- |
| 7 |
Psyence Biomedical |
229.39 Bn |
229.38 Bn |
- |
| 8 |
Vertex Pharmaceuticals |
113.09 Bn |
105.85 Bn |
2.59 Bn |
| 9 |
Abivax |
90.15 Bn |
90.15 Bn |
- |
| 10 |
Champions Oncology |
91.38 Mn |
84.37 Mn |
13.89 Mn |
| Date | Value |
|---|
| Jan 31, 2026 |
10.14% |
| Oct 31, 2025 |
7.43% |
| Jul 31, 2025 |
13.27% |
| Apr 30, 2025 |
-27.49% |
| Jan 31, 2025 |
26.32% |
| Oct 31, 2024 |
-4.07% |
| Jul 31, 2024 |
0.42% |
| Apr 30, 2024 |
16.50% |
| Jan 31, 2024 |
3.85% |
| Oct 31, 2023 |
-7.87% |
| Jul 31, 2023 |
-3.90% |
| Apr 30, 2023 |
2.33% |
| Jan 31, 2023 |
-10.56% |
| Oct 31, 2022 |
3.90% |
| Jul 31, 2022 |
6.74% |
| Apr 30, 2022 |
-2.40% |
| Jan 31, 2022 |
11.94% |
| Oct 31, 2021 |
4.74% |
| Jul 31, 2021 |
6.52% |
| Apr 30, 2021 |
-2.29% |
